Nicola Heffron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

-$1 73 Earnings Per Share Expected for 2seventy bio, Inc (NASDAQ:TSVT) This Quarter

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

United statesThomson reuterNicola heffronSecurities exchange commissionZacks investment researchGet ratingExchange commission

Analysts Expect 2seventy bio Inc (NASDAQ:TSVT) Will Post Quarterly Sales of $24 45 Million

Equities analysts expect 2seventy bio Inc (NASDAQ:TSVT – Get Rating) to announce sales of $24.45 million for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for 2seventy bio’s earnings. The highest sales estimate is $37.09 million and the lowest is $13.20 million. The company is scheduled to issue its next earnings results […]

United kingdomUnited statesNicola heffronSecurities exchange commissionZacks investment researchGet ratingInvestment researchExchange commission2seventy bioNasdaq tsvt

Short Interest in 2seventy bio Inc (NASDAQ:TSVT) Declines By 16 6%

2seventy bio Inc (NASDAQ:TSVT – Get Rating) was the recipient of a significant decline in short interest in February. As of February 28th, there was short interest totalling 2,010,000 shares, a decline of 16.6% from the February 13th total of 2,410,000 shares. Currently, 8.9% of the company’s shares are sold short. Based on an average […]

United kingdomUnited statesPhilipd gregoryNicola heffronZacks investment researchGet ratingInvestment research2seventy bioNasdaq tsvt

SVB Leerink Initiates Coverage on 2seventy bio (NASDAQ:TSVT)

SVB Leerink Initiates Coverage on 2seventy bio (NASDAQ:TSVT)
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Philipd gregoryNicola heffronMorgan stanleySecurities exchange commissionZacks investment researchInvestment researchExchange commission

Bluebird names oncology spinoff, establishes leadership team

Bluebird revealed the name of the oncology spinoff and the thinking behind the moniker. (Bluebird Bio) Bluebird bio has disclosed the name of its oncology spinoff: 2seventy bio. The spinoff is taking cancer therapies and some executives, including the CEO and chief scientific officer, from bluebird. Massachusetts-based bluebird first shared details of its plans to spin off its cancer assets into a new publicly traded company in January. Bluebird framed the separation as the way to best support both its cancer and rare disease assets given differences in the expertise needed to develop, manufacture and win approval for candidates in each space.

United statesAndrew obenshainPhilip gregoryNick leschlyNicola heffronChip bairdRich colvinஒன்றுபட்டது மாநிலங்களில்ஆண்ட்ரூ ஓபென்ஷ்ைன்பிலிப் கிரெகொரிநிகோலா ஹெஃப்ரான்சிப் பெயர்ட்பணக்கார கொல்வின்